Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
By B. Falini, C. Mecucci, E. Tiacci, M. Alcalay, R. Rosati, L. Pasqualucci, R. la Starza, D. Diverio, E. Colombo, A. Santucci and 13 more. New England Journal of Medicine, 2005
1,909 citations recorded by the source corpus.
Subfields: Hematology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/8b7326aebaf7f3f54c5a2c6e4fd9b05352299712
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hematology
In Molecular Biology
Citations in the corpus
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia (2010, background): “Mutations in exon 12 of the NPM1 gene, which result in aberrant cytoplasmic localization of the protein, constitute an independent favorable prognostic marker in AML (Falini et al., 2005).”
- Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action (2006, background): “NPM is frequently overexpressed in tumors of diverse origin (50, 262), and it is translocated in lymphomas and leukemias (96, 250).”
- DNMT3A Mutations in Acute Myeloid Leukemia (2010, neutral): “IDH1 12/218 (6) 10/37 (27) 3/25 (12) 13/62 (21) <0.”